創傷デブリードマンの世界市場：手法別、製品タイプ別、創傷タイプ別、エンドユーザー別、地域別、範囲および予測

創傷デブリードマンの市場規模と予測

創傷デブリードマン市場規模は2024年に10億9,000万米ドル、2031年には19億4,000万米ドルに達すると予測、2024年から2031年までのCAGRは8.16%。

創傷デブリードマンとは、死んだ組織、損傷した組織、感染した組織を医学的に除去し、残った健康な組織の治癒能力を向上させることです。

同市場は、病院、診療所、在宅ケアなど様々なヘルスケア環境に対応しており、糖尿病性足潰瘍、褥瘡、静脈性下腿潰瘍など様々なタイプの創傷に対するソリューションを提供しています。

創傷除去市場の将来は、慢性創傷の増加、高齢者人口の増加、創傷ケア技術の進歩、適切な創傷管理の重要性に対する意識の高まりによって形成されます。

創傷デブリードマンの世界市場力学

主な市場促進要因

慢性創傷の発生率の上昇：糖尿病、肥満、心血管疾患の増加により慢性創傷の発生率が上昇し、効果的なデブリードマンソリューションの需要が高まっています。

人口の高齢化：世界人口の高齢化に伴い、高齢者が慢性創傷にかかりやすくなっているため、デブリードマン処置を含む創傷ケアのニーズが高まっています。

技術の進歩：先進的な酵素的・自己溶解的デブリードマン製品など、創傷ケア技術における継続的な技術革新が治療成績を向上させ、市場成長の原動力となっています。

ヘルスケア支出の増加：先進国と発展途上国の両方でヘルスケア支出が増加しており、デブリードマン製品やサービスを含む先進的な創傷ケアソリューションの導入が促進されています。

主な課題：

高度なデブリードマン製品の高コスト：一部の先進的なデブリードマン製品や処置は比較的高価であるため、特に資源に制約のあるヘルスケア環境では、その導入が制限される可能性があります。

熟練したヘルスケア専門家の不足：創傷の適切なデブリードマンには専門的なスキルとトレーニングが必要です。高度創傷ケアに精通したヘルスケア専門家の不足は市場成長の妨げとなります。

償還の問題：地域によって創傷処置に対する償還方針が一貫していないため、高度なデブリードマンソリューションの採用に影響を与える可能性があります。

合併症のリスク：不適切なデブリードマン手技は出血、感染、さらなる組織損傷などの合併症を引き起こす可能性があり、医療従事者によっては積極的なデブリードマンの実施を躊躇する場合があります。

主な動向：

低侵襲デブリードマン法へのシフト：酵素法や自己溶解法など、侵襲性の低いデブリードマン法が好まれるようになってきています。

併用療法の採用増加：ヘルスケアプロバイダーは、創傷治癒の最適な結果を得るために複数のデブリードマン法を統合した併用アプローチを採用するようになっています。

バイオフィルム管理への注目：慢性創傷におけるバイオフィルムの役割に対する認識の高まりが、バイオフィルム除去に特化したデブリードマンソリューションの開発を促進しています。

在宅創傷管理に対する需要の高まり：在宅ケアの動向により、自己投与や介護者による塗布に適した使いやすいデブリードマン製品に対する需要が高まっています。

目次

第1章 創傷デブリードマンの世界市場：イントロダクション

• 市場概要
• 調査範囲
• 前提条件

第2章 エグゼクティブサマリー

第3章 VERIFIED MARKET RESEARCHの調査手法

• データマイニング
• バリデーション
• 一次資料
• データソース一覧

第4章 創傷デブリードマンの世界市場展望

• 概要
• 市場力学
  • 促進要因
  • 抑制要因
  • 機会
• ポーターのファイブフォースモデル
• バリューチェーン分析

第5章 創傷デブリードマンの世界市場：製品別

• 概要
• ジェル
• 軟膏
• 手術用デバイス
• 機械的剥離パッド
• 超音波デバイス
• その他

第6章 創傷デブリードマンの世界市場：創傷タイプ別

• 概要
• 静脈性下腿潰瘍
• 糖尿病性足潰瘍
• 褥瘡性潰瘍
• 熱傷
• その他

第7章 創傷デブリードマンの世界市場：手法別

• 概要
• 外科的
• 機械的
• 自己溶解
• 酵素的

第8章 創傷デブリードマンの世界市場：エンドユーザー別

• 概要
• 病院
• 診療所
• 在宅医療
• その他

第9章 創傷デブリードマンの世界市場：地域別

• 概要
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • その他欧州
• アジア太平洋
  • 中国
  • 日本
  • インド
  • その他アジア太平洋地域
• 世界のその他の地域
  • ラテンアメリカ
  • 中東・アフリカ

第10章 創傷デブリードマンの世界市場：競合情勢

• 概要
• 各社の市場ランキング
• 主な発展戦略

第11章 企業プロファイル

• Smith & Nephew
• B. Braun Melsungen AG
• Coloplast A/S
• ConvaTec Group plc
• Molnlycke Health Care AB
• Lohmann & Rauscher International GmbH & Co. KG
• DeRoyal Industries, Inc.
• Medline Industries, Inc.
• Integra LifeSciences Holdings Corporation
• Zimmer Biomet Holdings, Inc.

第12章 付録

• 関連レポート

Wound Debridement Market Size And Forecast

Wound Debridement Market size was valued at 1.09 USD Billion in 2024 and is projected to reach 1.94 USD Billion by 2031 growing at a CAGR of 8.16% from 2024 to 2031.

Wound debridement is the medical removal of dead, damaged, or infected tissue to improve the healing potential of the remaining healthy tissue.

The market serves various healthcare settings, including hospitals, clinics and homecare, offering solutions for different wound types such as diabetic foot ulcers, pressure ulcers and venous leg ulcers.

The future of the wound debridement market is shaped by increasing prevalence of chronic wounds, rising geriatric population, advancements in wound care technologies and growing awareness about the importance of proper wound management.

Global Wound Debridement Market Dynamics

The key market dynamics that are shaping the global wound debridement market include:

Key Market Drivers:

Rising Incidence of Chronic Wounds: The increasing prevalence of diabetes, obesity and cardiovascular diseases has led to a higher incidence of chronic wounds, driving the demand for effective debridement solutions.

Aging Population: As the global population ages, there is a growing need for wound care management, including debridement procedures, due to the higher susceptibility of older adults to chronic wounds.

Technological Advancements: Ongoing innovations in wound care technologies, such as advanced enzymatic and autolytic debridement products, are improving treatment outcomes and driving market growth.

Increasing Healthcare Expenditure: Rising healthcare spending in both developed and developing countries is facilitating the adoption of advanced wound care solutions, including debridement products and services.

Key Challenges:

High Cost of Advanced Debridement Products: The relatively high cost of some advanced debridement products and procedures can limit their adoption, particularly in resource-constrained healthcare settings.

Lack of Skilled Healthcare Professionals: Proper wound debridement requires specialized skills and training. The shortage of healthcare professionals with expertise in advanced wound care can hinder market growth.

Reimbursement Issues: Inconsistent reimbursement policies for wound care procedures across different regions can impact the adoption of advanced debridement solutions.

Risk of Complications: Improper debridement techniques can lead to complications such as bleeding, infection, or further tissue damage, which may deter some healthcare providers from performing aggressive debridement.

Key Trends:

Shift Towards Minimally Invasive Debridement Methods: There is a growing preference for less invasive debridement techniques, such as enzymatic and autolytic methods, which offer reduced pain and faster healing times.

Increasing Adoption of Combination Therapies: Healthcare providers are increasingly using combination approaches, integrating multiple debridement methods to achieve optimal wound healing outcomes.

Focus on Biofilm Management: Growing awareness of the role of biofilms in chronic wounds is driving the development of debridement solutions specifically targeting biofilm removal.

Rising Demand for Homecare Wound Management: The trend towards home-based care is increasing the demand for easy-to-use debridement products suitable for self-administration or application by caregivers.

Global Wound Debridement Market Regional Analysis

Here is a more detailed regional analysis of the global wound debridement market:

North America:

According to Verified Market Research, North America is expected to dominate the Global wound debridement market.

North America is expected to dominate the Global wound debridement market due to its advanced healthcare infrastructure and high healthcare expenditure.

The United States is a major contributor to market growth, driven by the high prevalence of chronic wounds, especially diabetic foot ulcers and a strong presence of key market players.

Canada's universal healthcare system and increasing focus on wound care management are also contributing to the expansion of the wound debridement market in the region.

The region's robust research and development activities in wound care technologies, supported by significant investments from both public and private sectors, are fostering innovation in debridement techniques and products.

Europe:

According to Verified Market Research, Europe is the fastest-growing region in the Global wound debridement market.

Europe represents a substantial market for wound debridement products and services, driven by the region's aging population and increasing prevalence of chronic diseases.

Countries like Germany, the UK, and France are key contributors to market growth, with their well-established healthcare systems and growing emphasis on advanced wound care techniques.

The region's stringent regulatory framework for medical devices is influencing the development of innovative and safe debridement solutions.

There is a growing trend towards multidisciplinary wound care teams in European healthcare settings, leading to more comprehensive and effective wound management strategies, including advanced debridement approaches.

Global Wound Debridement Market: Segmentation Analysis

The Global Wound Debridement Market is segmented on the basis of Method, Product, Wound Type, End-User, and Geography.

Wound Debridement Market, By Method

• Surgical
• Mechanical
• Autolytic
• Enzymatic

Based on Method, the Global Wound Debridement Market is divided into Surgical, Mechanical, Autolytic and Enzymatic segments. The Surgical segment currently dominates the market due to its effectiveness in rapidly removing large amounts of dead or infected tissue, making it ideal for severe or complex wounds. However, the Autolytic and Enzymatic segments are expected to show significant growth during the forecast period, driven by their minimally invasive nature, ease of use and reduced risk of damaging healthy tissue. The growing preference for patient-friendly treatment methods is further contributing to the rising demand for these alternatives.

Wound Debridement Market, By Product

• Gels
• Ointments
• Surgical Devices
• Mechanical Debridement Pads
• Ultrasonic Devices
• Others

Based on Product, the Global Wound Debridement Market is categorized into Gels, Ointments, Surgical Devices, Mechanical Debridement Pads, Ultrasonic Devices and Others. The Gels and Ointments segment is expected to lead the market during the forecast period due to their ease of use, effectiveness in autolytic debridement and suitability for home care settings. Surgical Devices also hold a significant market share, especially in hospital settings where more complex wound cases require precise removal of necrotic tissue. Additionally, advancements in ultrasonic technology and the increasing adoption of mechanical debridement pads are contributing to the growth of these segments.

Wound Debridement Market, By Wound Type

• Diabetic Foot Ulcers
• Pressure Ulcers
• Venous Leg Ulcers
• Burn Wounds
• Others

Based on Wound Type, the Global Wound Debridement Market is segmented into Diabetic Foot Ulcers, Pressure Ulcers, Venous Leg Ulcers, Burn Wounds and Others. The Diabetic Foot Ulcers segment currently leads the market due to the high prevalence of diabetes globally and the associated risk of foot ulcers, which require timely debridement to prevent complications. However, the Pressure Ulcers segment is expected to show significant growth, driven by the rising geriatric population, longer hospital stays and increasing awareness about pressure ulcer prevention and management strategies. The Venous Leg Ulcers and Burn Wounds segments are also witnessing growth due to advancements in wound care solutions and debridement techniques.

Wound Debridement Market, By End-User

• Hospitals
• Clinics
• Homecare
• Others

Based on End-User, the Global Wound Debridement Market is divided into Hospitals, Clinics, Homecare and Others. The hospital segment currently dominates the market due to the availability of advanced wound care facilities, skilled healthcare professionals, and access to a wide range of treatment options. However, the Homecare segment is expected to show the fastest growth during the forecast period, driven by the increasing trend towards home-based care, the rising prevalence of chronic wounds, and the development of easy-to-use debridement products designed for self-administration. This shift is further supported by growing patient preferences for convenience and comfort in managing their health at home.

Wound Debridement Market, By Geography

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East & Africa

Based on Geography, the Global Wound Debridement Market is divided into North America, Europe, Asia-Pacific, Latin America and the Middle East and Africa. North America leads the market, driven by advanced healthcare infrastructure, high healthcare expenditure and a large patient population with chronic wounds. Europe follows closely, with a strong focus on wound care management and an aging population. Asia-Pacific is the fastest-growing region, fueled by improving healthcare access, rising awareness about advanced wound care and increasing prevalence of chronic diseases.

Key Players

• The Global Wound Debridement Market study report will provide valuable insight with an emphasis on the global market. The major players in the Wound Debridement Market include Smith & Nephew plc, B. Braun Melsungen AG, Coloplast A/S, ConvaTec Group plc, Molnlycke Health Care AB, Lohmann & Rauscher International GmbH & Co. KG, DeRoyal Industries, Inc., Medline Industries, Inc., Integra LifeSciences Holdings Corporation and Zimmer Biomet Holdings, Inc.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share and market ranking analysis of the above-mentioned players globally.

• Wound Debridement Market Recent Developments
• In February 2024, Smith & Nephew plc launched a new enzymatic debridement product with enhanced proteolytic activity, designed to provide faster and more effective removal of necrotic tissue in chronic wounds.
• In May 2024, Molnlycke Health Care AB announced a strategic partnership with a leading AI company to develop smart wound assessment tools, including capabilities for automated debridement guidance and wound progress tracking.

TABLE OF CONTENTS

1. INTRODUCTION OF GLOBAL WOUND DEBRIDEMENT MARKET

• 1.1. Overview of the Market
• 1.2. Scope of Report
• 1.3. Assumptions

2. EXECUTIVE SUMMARY

3. RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1. Data Mining
• 3.2. Validation
• 3.3. Primary Interviews
• 3.4. List of Data Sources

4. GLOBAL WOUND DEBRIDEMENT MARKET OUTLOOK

• 4.1. Overview
• 4.2. Market Dynamics
  • 4.2.1. Drivers
  • 4.2.2. Restraints
  • 4.2.3. Opportunities
• 4.3. Porters Five Force Model
• 4.4. Value Chain Analysis

5. GLOBAL WOUND DEBRIDEMENT MARKET, BY PRODUCT

• 5.1. Overview
• 5.2. Gels
• 5.3. Ointments
• 5.4. Surgical Devices
• 5.5. Mechanical Debridement Pads
• 5.6. Ultrasonic Devices
• 5.7. Other

6. GLOBAL WOUND DEBRIDEMENT MARKET, BY WOUND TYPE

• 6.1. Overview
• 6.2. Venous Leg Ulcers
• 6.3. Diabetic Foot Ulcers
• 6.4. Pressure Ulcers
• 6.5. Burn Wounds
• 6.6. Other

7. GLOBAL WOUND DEBRIDEMENT MARKET, BY METHOD

• 7.1. Overview
• 7.2. Surgical
• 7.3. Mechanical
• 7.4. Autolytic
• 7.5. Enzymatic

8. GLOBAL WOUND DEBRIDEMENT MARKET, BY END USER

• 8.1. Overview
• 8.2. Hospitals
• 8.3. Clinics
• 8.4. Homecare
• 8.5 Other

9. GLOBAL WOUND DEBRIDEMENT MARKET, BY GEOGRAPHY

• 9.1. Overview
• 9.2. North America
  • 9.2.1. U.S.
  • 9.2.2. Canada
  • 9.2.3. Mexico
• 9.3. Europe
  • 9.3.1. Germany
  • 9.3.2. U.K.
  • 9.3.3. France
  • 9.3.4. Rest of Europe
• 9.4. Asia Pacific
  • 9.4.1. China
  • 9.4.2. Japan
  • 9.4.3. India
  • 9.4.4. Rest of Asia Pacific
• 9.5. Rest of the World
  • 9.5.1. Latin America
  • 9.5.2. Middle East & Africa

10. GLOBAL WOUND DEBRIDEMENT MARKET COMPETITIVE LANDSCAPE

• 10.1. Overview
• 10.2. Company Market Ranking
• 10.3. Key Development Strategies

11. COMPANY PROFILES

• Smith & Nephew
• B. Braun Melsungen AG
• Coloplast A/S
• ConvaTec Group plc
• Molnlycke Health Care AB
• Lohmann & Rauscher International GmbH & Co. KG
• DeRoyal Industries, Inc.
• Medline Industries, Inc.
• Integra LifeSciences Holdings Corporation
• Zimmer Biomet Holdings, Inc.

12. Appendix

• 12.1. Related Reports